000 01595 a2200445 4500
005 20250510211258.0
264 0 _c19790829
008 197908s 0 0 eng d
022 _a0090-4295
024 7 _a10.1016/0090-4295(79)90401-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFinkbeiner, A E
245 0 0 _aUropharmacology: XI. Adrenergic-blocking agents and drugs affecting catecholamine binding and release.
_h[electronic resource]
260 _bUrology
_cJun 1979
300 _a693-700 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic Agents
_xpharmacology
650 0 4 _aAdrenergic alpha-Antagonists
_xpharmacology
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBretylium Compounds
_xpharmacology
650 0 4 _aDihydroergotamine
_xpharmacology
650 0 4 _aGuanethidine
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethyldopa
_xpharmacology
650 0 4 _aMuscle, Smooth
_xdrug effects
650 0 4 _aPhenoxybenzamine
_xpharmacology
650 0 4 _aPhentolamine
_xpharmacology
650 0 4 _aPropranolol
_xpharmacology
650 0 4 _aUrethra
_xdrug effects
650 0 4 _aUrinary Bladder
_xdrug effects
650 0 4 _aUrinary Bladder, Neurogenic
_xdrug therapy
650 0 4 _aUrinary Tract
_xdrug effects
650 0 4 _aUrination Disorders
_xdrug therapy
700 1 _aWelch, L T
700 1 _aBissada, N K
773 0 _tUrology
_gvol. 13
_gno. 6
_gp. 693-700
856 4 0 _uhttps://doi.org/10.1016/0090-4295(79)90401-1
_zAvailable from publisher's website
999 _c86120
_d86120